Investment Analysts’ Weekly Ratings Updates for Anthem (ANTM)

Several analysts have recently updated their ratings and price targets for Anthem (NYSE: ANTM):

  • 2/2/2018 – Anthem was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.
  • 2/1/2018 – Anthem had its “outperform” rating reaffirmed by analysts at Credit Suisse Group AG. They now have a $280.00 price target on the stock, up previously from $255.00.
  • 2/1/2018 – Anthem had its price target raised by analysts at Morgan Stanley from $247.00 to $266.00. They now have an “equal weight” rating on the stock.
  • 2/1/2018 – Anthem had its price target raised by analysts at Wells Fargo & Co from $260.00 to $275.00. They now have an “outperform” rating on the stock.
  • 1/31/2018 – Anthem had its “buy” rating reaffirmed by analysts at Cowen Inc. They now have a $280.00 price target on the stock.
  • 1/19/2018 – Anthem had its “buy” rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $275.00 price target on the stock.
  • 1/12/2018 – Anthem was upgraded by analysts at Jefferies Group LLC from a “hold” rating to a “buy” rating. They now have a $211.00 price target on the stock, down previously from $235.00.
  • 1/4/2018 – Anthem had its “buy” rating reaffirmed by analysts at Royal Bank of Canada.
  • 1/3/2018 – Anthem was upgraded by analysts at Zacks Investment Research from a “hold” rating to a “buy” rating. They now have a $253.00 price target on the stock. According to Zacks, “Anthem's shares have outperformed the industry in a year’s time. Its diverse product portfolio has helped in improving underwriting results. Its strategic acquisitions, divestitures and ACO arrangements pave the way for long-term growth. The company’s rising level of medical membership continues to boost the top line. Its strong capital position backs effective capital deployment via share buyback programs and regular dividend payments. Followed by strong third-quarter 2017 results, the company raised earnings guidance for 2017. However, loss incurred on public exchange business continues to bother. Also rising level of debt and expenses keep draining the margins.”
  • 1/3/2018 – Anthem is now covered by analysts at Goldman Sachs Group Inc. They set a “neutral” rating and a $243.00 price target on the stock.
  • 1/3/2018 – Anthem was upgraded by analysts at Piper Jaffray Companies from a “neutral” rating to an “overweight” rating. They now have a $151.00 price target on the stock.
  • 1/2/2018 – Anthem was downgraded by analysts at Zacks Investment Research from a “buy” rating to a “hold” rating. According to Zacks, “Anthem's shares have outperformed the industry in a year’s time. Its diverse product portfolio has helped in improving underwriting results. Its strategic acquisitions, divestitures and ACO arrangements pave the way for long-term growth. The company’s rising level of medical membership continues to boost the top line. Its strong capital position backs effective capital deployment via share buyback programs and regular dividend payments. Followed by strong third-quarter 2017 results, the company raised earnings guidance for 2017. However, loss incurred on public exchange business continues to bother. Also rising level of debt and expenses keep draining the margins.”
  • 12/31/2017 – Anthem was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating.

Anthem Inc (NYSE ANTM) opened at $232.77 on Tuesday. The company has a current ratio of 1.55, a quick ratio of 1.51 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $59,770.00, a price-to-earnings ratio of 16.21, a price-to-earnings-growth ratio of 1.33 and a beta of 0.83. Anthem Inc has a 12-month low of $158.66 and a 12-month high of $267.95.

Anthem (NYSE:ANTM) last posted its quarterly earnings data on Wednesday, January 31st. The company reported $1.29 earnings per share for the quarter, topping the consensus estimate of $1.25 by $0.04. The firm had revenue of $22.45 billion for the quarter, compared to analysts’ expectations of $22.17 billion. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The company’s quarterly revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the business earned $1.76 EPS. sell-side analysts forecast that Anthem Inc will post 15.09 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 9th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, March 8th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.29%. This is a boost from Anthem’s previous quarterly dividend of $0.70. Anthem’s dividend payout ratio (DPR) is presently 19.50%.

In related news, EVP Gloria M. Mccarthy sold 14,429 shares of the firm’s stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $229.68, for a total value of $3,314,052.72. Following the transaction, the executive vice president now owns 30,667 shares in the company, valued at $7,043,596.56. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Joseph Swedish sold 21,125 shares of the firm’s stock in a transaction on Friday, December 1st. The stock was sold at an average price of $231.43, for a total value of $4,888,958.75. Following the completion of the transaction, the chairman now owns 87,668 shares in the company, valued at approximately $20,289,005.24. The disclosure for this sale can be found here. Insiders sold 167,457 shares of company stock worth $39,862,398 in the last 90 days. 0.36% of the stock is owned by company insiders.

Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.

Receive News & Ratings for Anthem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply